Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS
Content archived on 2024-06-16

TASK-FORCE IN EUROPE FOR DRUG DEVELOPMENT FOR THE YOUNG

Objective

The knowledge generated by the sequencing of the human genome will enable the development of more effective strategies for preventing, diagnosing and treating human diseases, and consequently decrease morbidity and mortality. One can therefore anticipate that children should benefit from advances of the genome era.
Application of advances in genomics, biotechnology and therapeutics to provide children with more efficacious and safer medicines will require the development of a new research matrix that integrates scientific domains, assesses impact of findings and implements policies. Furthermore, any attempt to integrate genetic information into medical practice ought to consider human development and maturation, from the prenatal period through adolescence.
TEDDY project is aimed at optimising the paediatric use of current drugs and promoting the development of new drugs, by incorporating pharmacogenetic applications and implementing guidance/tools to perform paediatric research. Special attention will be paid to variability in response, particularly, the role of gender factors and time-dependencies associated with the development from prenatal period to adolescence. A framework will be developed to characterise adverse drug reactions and optimise dosing regimens, including research projects on pharmacogenetic variants. Harmonised databases and guidelines will be created for marketed medicines. Training programmes on ethics, scientific and clinical skills will be set up to increase research capacity and promote social awareness.
The proposed network will include stakeholders in drug development and paediatric clinical practice. European academics, scientists, healthcare specialists and ethics experts will work together with pharmaceutical companies, regulatory agencies and patients associations to implement a common mission. A strong link with existing European networks running clinical trials in children, such as PENTA and PRINTO, will be established.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.

You need to log in or register to use this function

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

FP6-2003-LIFESCIHEALTH-I
See other projects for this call

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

NoE - Network of Excellence

Coordinator

CONSORZIO PER VALUTAZIONI BIOLOGICHE E FARMACOLOGICHE
EU contribution
No data
Address
VIA PALESTRO 26
PAVIA
Italy

See on map

Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

No data

Participants (18)

My booklet 0 0